SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Gland Pharma reports 7% rise in Q3 consolidated net profit

03 Feb 2025 Evaluate

Gland Pharma has reported results for third quarter ended December 31, 2024 (Q3FY25)

The company has reported 6.62% rise in net profit at Rs 295.12 crore for Q3FY25 as compared to Rs 276.81 crore for the same quarter in the previous year. However, total income of the company decreased by 5.73% at Rs 1075.85 crore for Q3FY25 as compared to Rs 1141.25 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 6.69% rise in its net profit at Rs 204.69 crore for the quarter ended December 31, 2024 as compared to Rs 191.86 crore for the same quarter in the previous year. However, total income of the company decreased by 8.85% at Rs 1442.55 crore for Q3FY25 as compared to Rs 1582.55 crore for the corresponding quarter previous year.

Gland Pharma Share Price

1736.00 -20.00 (-1.14%)
16-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1693.15
Dr. Reddys Lab 1221.25
Cipla 1230.75
Zydus Lifesciences 939.20
Lupin 2326.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×